Status:
COMPLETED
Assessment of Bone Density and Bone Turnover Markers in Patients With Down Syndrome and Comparison to the Ts65Dn Model
Lead Sponsor:
University of Arkansas
Conditions:
Down Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study may provide information that may serve as the foundation for a larger research study to address issues regarding the causes, diagnosis, and treatment of osteoporosis in the Down syndrome pa...
Detailed Description
Osteoporosis is responsible for more than 1.5 million fractures and $14 billion in medical care costs annually (U.S Dept of Health and Human Services data, 2006). Down syndrome is an independent risk ...
Eligibility Criteria
Inclusion
- Males and Females of all races and ethnicities
- Age 18 or older and current clinical diagnosis of Down Syndrome
Exclusion
- No legally authorized representative (if applicable) willing to provide informed consent. Any condition the investigator determines will put the subject at risk by participating in the study.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01148121
Start Date
June 1 2010
End Date
August 1 2015
Last Update
December 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205